Merit Medical

Merit Medical specializes in vascular and interventional cardiology devices. Their portfolio includes vascular catheter introduction sets (both standard and hydrophilic-coated for easier insertion), cardiac transseptal access sets and needles for single-use in procedures like atrial septal defect closures, haemostasis valves to manage bleeding at catheter insertion sites, and intravascular catheter slitters designed to cut and remove occluded catheters. These products are primarily used in procedural settings to improve access, precision, and safety during interventions.

Merit Medical is based in the United States, which means its devices are subject to FDA regulations. The company’s products are classified under FDA’s risk-based system as either Class I (generally low-risk) or Class II (requiring special controls to ensure safety and effectiveness). All listed devices appear in the FDA’s Unique Device Identifier (UDI) database, demonstrating compliance with mandatory identification requirements for medical devices marketed in the U.S.

Merit Medical’s devices are included in the FDA’s Unique Device Identifier (UDI) database. The UDI system assigns a unique product code to each distinct device, enabling transparent tracking, traceability, and regulatory oversight. This listing helps healthcare providers, regulators, and other stakeholders verify and access critical information about the company’s products, such as device descriptions, manufacturing details, and compliance status.

Merit Medical’s devices are classified as either Class I or Class II under the FDA’s medical device classification system. Class I devices, like some haemostasis valves or basic catheter introduction sets, typically pose minimal risk and may only require general controls (e.g., good manufacturing practices). Class II devices, such as specialized transseptal needles or advanced catheter systems, require additional performance standards or post-market surveillance to ensure safety and efficacy. The classification determines the regulatory pathway and scrutiny each product undergoes.